2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Vomiting
1
Rectal Neoplasms
1
Patient Compliance
1
Nausea
1
Liver Neoplasms
1
Breast Neoplasms
1
Interventions
Exercise
3
Patient Navigation
2
Interviews as Topic
2
Anastrozole
2
regorafenib
1
potassium oxonate
1
beta-Aminoethyl Isothiourea
1
Weights and Measures
1
Videotape Recording
1
Trastuzumab
1
Surveys and Questionnaires
1
Standard of Care
1
Specimen Handling
1
Self Care
1
Radiation
1
Psychosocial Intervention
1
Oxaliplatin
1
Ocoxin
1
Nutrition Assessment
1
N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine
1
Motivational Interviewing
1
Metabolism
1
Leuprolide
1
Lapatinib
1
Goserelin
1
Diet Therapy
1
Diet
1
Clodronic Acid
1
Cisplatin
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Patient Compliance
×
Acupuncture Points
×
Clear all
NCT04749381
2021-02-11
RCT
Peking University Cancer Hospital & Institute
Phase 2
Unknown
264 enrolled